Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2189]
News [5863]
Articles [114]
Editorials [31]
Conferences [184]
elearning [22]
ESMO 2017: Debate on duration of colon cancer adjuvant chemotherapy takes centre stage at ESMO 2017
ESMO 2017: Debate on duration of colon cancer adjuvant chemotherapy takes centre stage at ESMO 2017
ESMO 2017: Combination targeted adjuvant therapy doubles relapse-free survival in stage III melanoma
ESMO 2017: Combination targeted adjuvant therapy doubles relapse-free survival in stage III melanoma
ESMO 2017: KEYNOTE-040 evaluates pembrolizumab in head and neck cancer
ESMO 2017: KEYNOTE-040 evaluates pembrolizumab in head and neck cancer
ESMO 2017: Adjuvant nivolumab superior to ipilimumab in surgically resected stage III/IV melanoma
ESMO 2017: Adjuvant nivolumab superior to ipilimumab in surgically resected stage III/IV melanoma
ESMO 2017: Updated results of the SCOT study
ESMO 2017: Updated results of the SCOT study
ESMO 2017: Combined lenvatinib and pembrolizumab produces notable response rates in advanced renal carcinoma
ESMO 2017: Combined lenvatinib and pembrolizumab produces notable response rates in advanced renal carcinoma
ESMO 2017: Mature results favour pembrolizumab as second-line treatment for bladder cancer
ESMO 2017: Mature results favour pembrolizumab as second-line treatment for bladder cancer
ESMO 2017: Combination immunotherapy in second/third line extends mesothelioma survival to 15 months
ESMO 2017: Combination immunotherapy in second/third line extends mesothelioma survival to 15 months
ESMO 2017: Study shows ESMO Magnitude of Benefit Scale can be used to grade orphan drugs
ESMO 2017: Study shows ESMO Magnitude of Benefit Scale can be used to grade orphan drugs
ESMO 2017: Osimertinib improves progression-free survival in patients with EGFR mutated lung cancer
ESMO 2017: Osimertinib improves progression-free survival in patients with EGFR mutated lung cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation